ABAT · sample dossier
52/100
OutdatedGenerated Sep 12, 2026 · 10:00 AM UTC · 55 days ago
This copy is frozen (Sep 12). Sign in to run the same work — filings, valuation, bull and bear, sources — on any US stock or ETF, in about 90 seconds.
Run a fresh dossierAmerican Battery Technology Company Common Stock · XNAS
Recommendation
Weighed down by weak Momentum (16/100) and Quality (27/100) scores.
A mixed picture — no strong reason to buy or sell right now.
AlphaDog Fair Value
Executive Investment Thesis
American Battery Technology Company (ABAT) is an energy transition materials firm capitalized at $336.94M trading at $2.47 as of 2026-09-12, with negative profitability reflected in an EV/EBITDA of -5.29 and Price/Book of 2.90. Despite top-line Revenue Growth YoY of 697.1%, unprofitability persists with Gross Margin at -42.7%, ROA at -39.7%, and 3-month share price returns down 27.8% as of 2026-09-12. The single biggest risk is aggressive shareholder dilution of +75.1% YoY coupled with an alarming Beneish M-score of 6.02 indicating earnings manipulation risk.
Key Metrics to Watch
No material changes found in the last 30 days.
Score 52 · Hold
Mar 31, 2026
Growth scores 100/100 — top-line expansion leads the profile.
Levels unavailable — AlphaDog quantitative valuation model did not produce an estimate from comps or DCF
Re-evaluate if
Trim / reconsider if
Think of these dollars as a map of our value estimate for Hold — helpful context, not a reason to override the view.
A Calmer Look · Devil's Advocate
The prevailing consensus fixates on top-line hyper-growth of 697.1% YoY and an unleveraged balance sheet with a Debt/Equity of 0.00, while the bear debate focuses almost exclusively on past dilution of +75.1% YoY.
May be overlooked
Financial disclosure staleness
The debate evaluates operational momentum using quarterly filings from March 31, 2026, which are more than 160 days stale as of 2026-09-12, concealing trailing summer cash burn and inventory obsolescence.
Insider purchase insignificance
The cited bullish insider cluster of 411,905 net shares accounts for less than 0.35% of total shares outstanding and fails to meaningfully counter the 75.1% YoY dilution rate.
Gross level cash burn
Consensus treats top-line expansion to $7.81M as a commercial inflection, ignoring that negative gross margins of -42.7% mean revenue scale increases cash drain before accounting for SG&A or capex.
Expectations look stretched
Uncritical reliance on Altman Z-score
The safe Altman Z-score of 14.39 is artificially inflated by zero debt (D/E 0.00) and equity market value rather than operating resilience, masking an ROA of -39.7%.
Extrapolation of revenue growth without unit viability
Bullish sentiment surrounding 697.1% YoY revenue growth presumes operating leverage that does not exist, as reflected by a negative EV/EBITDA of -5.3 and P/E of -4.8.
Rich asset valuation despite negative returns
The market assigns a Price/Book multiple of 2.90 to a balance sheet that generated a -27.8% three-month stock return and an ROA of -39.7%.
Revenue Growth YoY falls below 697.1%
Revenue Growth YoY falls below 697.1%
Snapshot returns at report publication
1 month
-2.0%
3 months
-27.8%
6 months
-27.8%
1 year
+8.3%
At a Glance
A smaller company is in a pullback at unprofitable earnings.
Top Holders
Financial Performance
Go deeper
For learning and research only — not investment advice. AlphaDog doesn’t hold stocks and isn’t your financial advisor.
You just read a full ABAT dossier — scored verdict, valuation, and both sides, with sources. Sign in to run that on a name you hold, on current filings. A free account includes 10 credits a week, 1 per fresh run.